Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,202 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 1-22 of 22 matching filings.

Per page
25
Current page
1
10-K File 000-21990

10-K filing

Filing date
15 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
10-K File 000-21990

10-K filing

Filing date
12 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
10-K/A File 000-21990

10-K/A filing

Filing date
20 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-K File 000-21990

10-K filing

Filing date
14 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
10-K File 000-21990

10-K filing

Filing date
15 Apr 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
10-K File 000-21990

10-K filing

Filing date
15 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
10-K/A File 000-21990

10-K/A filing

Filing date
20 May 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-21990

10-K filing

Filing date
14 May 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
10-K/A File 000-21990

FORM 10-K/A

Filing date
29 Apr 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-21990

FORM 10-K/A

Filing date
02 May 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-21990

FORM 10-K

Filing date
16 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-21990

OXIGENE, INC.

Filing date
29 Apr 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-21990

FORM 10-K

Filing date
16 Mar 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .